Cargando…
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease
Alcohol-related liver disease (ALD) is a major cause of liver disease and represents a global burden, as treatment options are scarce. Whereas 90% of ethanol abusers develop alcoholic fatty liver disease (AFLD), only a minority evolves to steatohepatitis and cirrhosis. Alcohol increases lipogenesis...
Autores principales: | Sangineto, Moris, Grander, Christoph, Grabherr, Felix, Mayr, Lisa, Enrich, Barbara, Schwärzler, Julian, Dallio, Marcello, Bukke, Vidyasagar Naik, Moola, Archana, Moschetta, Antonio, Adolph, Timon E., Sabbà, Carlo, Serviddio, Gaetano, Tilg, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255095/ https://www.ncbi.nlm.nih.gov/pubmed/35786161 http://dx.doi.org/10.1080/19490976.2022.2089006 |
Ejemplares similares
-
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease
por: Sangineto, Moris, et al.
Publicado: (2020) -
A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model
por: Sangineto, Moris, et al.
Publicado: (2021) -
Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression
por: Adolph, Timon E., et al.
Publicado: (2018) -
Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2021) -
Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2022)